BTIG Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsInitiationPrice Target
BTIG analyst Sam Eiber initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and announces Price Target of $5.
BTIG analyst Sam Eiber initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and announces Price Target of $5.